miR-181 interacts with signaling adaptor molecule DENN/MADD and enhances TNF-induced cell death

被引:13
作者
Ghorbani, Samira [1 ,2 ]
Talebi, Farideh [1 ]
Ghasemi, Sedigheh [2 ]
Abad, Ali Jahanbazi Jahan [2 ]
Vojgani, Mohammed [1 ]
Noorbakhsh, Farshid [1 ,3 ]
机构
[1] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran
[2] Khatam AI Anbia Hosp, Shefa Neurosci Res Inst, Tehran, Iran
[3] Iran Univ Med Sci, Razi Drug Res Ctr, Tehran, Iran
来源
PLOS ONE | 2017年 / 12卷 / 03期
关键词
NECROSIS-FACTOR TNF; ACTIVATED PROTEIN-KINASE; MULTIPLE-SCLEROSIS; MICRORNA TARGETS; GENE-EXPRESSION; FACTOR RECEPTOR; FACTOR-ALPHA; IG20; GENE; TUMOR; APOPTOSIS;
D O I
10.1371/journal.pone.0174368
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MicroRNAs are small noncoding RNAs, which regulate the expression of protein coding transcripts through mRNA degradation or translational inhibition. Numerous reports have highlighted the role of miRNAs in regulating cell death pathways including the expression of genes involved in the induction of apoptosis. Tumor necrosis factor alpha (TNF-alpha) is a proinflammatory cytokine which can send pro-death signals through its receptor TNFR1. Diverse adaptor molecules including DENN/MADD adaptor protein have been shown to modulate TNF-alpha pro-death signaling via recruitment of MAP kinases to TNFR1 and activation of pro-survival NF kappa B signaling. Herein, we investigated the role of microRNA-181 (miR-181) in regulating DENN/MADD expression levels and its subsequent effects on TNF-alpha-induced cell death. Using bioinformatics analyses followed by luciferase reporter assays we showed that miR-181 interacts with the 3' UTR of DENN/MADD transcripts. miR-181 overexpression also led to decreased endogenous DENN/MADD mRNA levels in L929 murine fibroblasts. Flow cytometric analysis of miR-181 transfected cells showed this miRNA accentuates mitochondrial membrane potential loss caused by TNF-alpha. These findings were associated with enhanced apoptosis of L929 cells following TNF-alpha treatment. Overall, these data point to the potential role of miR-181 in regulating TNF-alpha pro-death signaling, which could be of importance from pathogenesis and therapeutic perspectives in inflammatory disorders associated with tissue degeneration and cell death.
引用
收藏
页数:14
相关论文
共 44 条
[1]   microRNAs: Tiny regulators with great potential [J].
Ambros, V .
CELL, 2001, 107 (07) :823-826
[2]   TNF-mediated inflammatory disease [J].
Bradley, J. R. .
JOURNAL OF PATHOLOGY, 2008, 214 (02) :149-160
[3]   Regulation of tumour necrosis factor signalling: live or let die [J].
Brenner, Dirk ;
Blaser, Heiko ;
Mak, Tak W. .
NATURE REVIEWS IMMUNOLOGY, 2015, 15 (06) :362-374
[4]   Engagement of tumor necrosis factor (TNF) receptor 1 leads to ATF-2-and p38 mitogen-activated protein kinase-dependent TNF-α gene expression [J].
Brinkman, BMN ;
Telliez, JB ;
Schievella, AR ;
Lin, LL ;
Goldfeld, AE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (43) :30882-30886
[5]   MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2 [J].
Chen, Gong ;
Zhu, Wei ;
Shi, Dezhi ;
Lv, Li ;
Zhang, Chun ;
Liu, Ping ;
Hu, Weixing .
ONCOLOGY REPORTS, 2010, 23 (04) :997-1003
[6]   miR-181a Regulates Cap-Dependent Translation of p27kip1 mRNA in Myeloid Cells [J].
Cuesta, Rafael ;
Martinez-Sanchez, Aida ;
Gebauer, Fatima .
MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (10) :2841-2851
[7]   Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons [J].
Del Villar, K ;
Miller, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (12) :4210-4215
[8]  
Efimova E, 2003, CANCER RES, V63, P8768
[9]   IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs [J].
Efimova, EV ;
Al-Zoubi, AM ;
Martinez, O ;
Kaithamana, S ;
Lu, SF ;
Arima, T ;
Prabhakar, BS .
ONCOGENE, 2004, 23 (05) :1076-1087
[10]   TNF-Alpha as a Therapeutic Target in Inflammatory Diseases, Ischemia-Reperfusion Injury and Trauma [J].
Esposito, E. ;
Cuzzocrea, S. .
CURRENT MEDICINAL CHEMISTRY, 2009, 16 (24) :3152-3167